Brief: Agios Presents Positive Results From Phase 3 Energize-T Study Of Mitapivat At Ash 2024 And Provides Regulatory Update On Mitapivat

Agios Pharmaceuticals

08/12/2024 17:42

Dec 8 (Reuters) - Agios Pharmaceuticals Inc  AGIO.O :
    * AGIOS PRESENTS POSITIVE RESULTS FROM PHASE 3 ENERGIZE-T
STUDY OF
MITAPIVAT AT ASH 2024 AND PROVIDES REGULATORY UPDATE ON
MITAPIVAT
    * AGIOS PHARMACEUTICALS - FILED REGULATORY APPLICATIONS FOR
MITAPIVAT US, EU, SAUDI ARABIA ,UAE

Source text:  ID:nGNXZTXPq 
Further company coverage:  AGIO.O 

 ((Reuters.Briefs@thomsonreuters.com;;))